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Abstract 
A kinetic analysis of cleavage of simian virus DNA (SV40 DNA) inside and outside green monkey BSC-I cells by 
the enediyne-protein antibiotic C-1027 and its free chromophore is described. Information on rate constants was 
obtained by fitting populations of forms I (closed circular DNA), II (nicked circular DNA) and III (linear DNA) of 
SV4f.J DNA as a function of drug concentration to a kinetic model which includes: cutting of form I to give form II 
with rate constant k1. cutting of form I to give form III with rate constant k4, and cutting of form II to give form III 
with rate constant k2. Theratio of single-strand (ss) to double-strand (ds) cutting for the holoantibiotic and the free 
chromophore. k1/k4, is approximately 1.8 for extracellular SV40 DNA. For intracellular DNA and extracellular DNA 
which has been post-treated with putrescine, ds cutting is much more probable, with k4, about four times as large as 
k1. This observation suggests that amine groups present in the cell are able to convert abasic sites opposite an ss 
break into a ds break in SV40 chkomatin. The overall rate of cleavage of form-1 DNA inside the cell is much larger 
than the rate outside, the sum k1 + k4 being about three times as large for intracellular DNA as for extracellular 
DNA. 
 
1. Introduction 
Most studies on the mechanism of action of anticancer drugs have focused on the selectivity of the agents for 
specific sequences and on the details of their binding modes with DNA [l-3]. Since sequence specificities of 
clinically used anticancer drugs are relatively low [4] and different drugs with different binding modes produce the 
same end effect, i.e., the death of the cell, sequence specificity and the mode of interaction are probably less 
important than the rate at which the drug produces lesions in DNA. The cell, which is constantly suffetting damage 
from numerous sources, has available ‘repair processes for correcting lesions in DNA [5-8]. If the rate of damage by 
the drug exceeds the rate of repair by the repair systems, the cell will die. Clearly, measuring the rates of damage 
and repair in cancer and normal cells is an important determinant of the therapeutic efficacy of the drug. 
SV40 DNA can exist in three forms: closed circu-[end of page 201] lar (form I), nicked circular (form II), 
and linear (form III). A nick on one strand by the drug C-1027 converts form I to form II. A second nick will convert 
form II to form III if it is on the opposite strand and is sufficiently close to the first nick. Previously, we studied 
cleavage of SV40 DNA inside BSC-1 monkey cells [9] and DNA in the nucleus and mitochondria of the episome-
containing cell line, 935.1 [10], using the enediyne antitumor drug, C-1027 [11,12]. In this report we present the 
kinetic theory and measure rate parameters associated with cleavage of SV40 DNA inside and outside BSC-I green 
monkey cells using the holoantibiotic and the free chromophore of C-1027. 
 
2. Materials and Methods 
 
2.1. Chemicals and Reagents 
The antitumor antibiotic C-1027 was supplied by the Taiho Pharmaceutical Co. (Tokushima, Japan). Stock solutions 
of the drug in water were stored at -20°C in the dark. SV40 DNA (strain 776) was used as obtained from GIBCO-
BRL (Grand Island, NY). All DNA concentrations are stated in base pairs. 
 
2.2. Cleavage of Extracellular SV40 DNA by the Holoantibiotic 
 
 
Due to the photosensitivity of C-1027 [11], the following cleavage reactions were carried out under 
subdued light using a photographic safety light (Kodak GBX-2). Stock solutions of the drug in water (66 μM) were 
stored in the dark at -20°C until needed. The cleavage reactions were at room temperature in a total volume of 40 μ1 
of buffer (30 mM Tris-acetate, 0.75 mM EDTA, pH 8.0) containing 63 μM of SV40 DNA. Reactions were 
performed using total final drug concentrations of (μM): 1.32, 1.19, 1.06, 0.92, 0.79, 0.66, 0.53, 0.40, 0.26, 0.13. 
After 15 min the DNA was separated by electrophoresis in a 1% agarose gel in 1 X TAE buffer. The gel was 
prepared by addition of 1 g of low melting agarose to 100 ml of 1 X TAE buffer. After heating to boiling, the 
solution was poured into the gel casting and cooled to room temperature [13]. Next, the DNA was visualized by 
soaking the gel in an ethidium bromide solution (0.5 μg ml-1) for 2 h. Using these conditions the order of 
electrophoretic mobility in the gel is: form I (fastest moving) > form III > form II (slowest moving) [13]. The gel, 
without destaining, was placed on a UV transilluminator and photographed with a Polaroid camera using type-55 
film. The exposure time was such that the maximum intensity of all bands was in the linear response range of the 
film. Linearity of measured intensity with DNA was checked by loading different amounts of DNA into the gel, and 
after electrophoresis, staining and photography, constructing plots of band intensity versus DNA concentration. The 
photographic negative was scanned with a Molecular Dynamics (model 300A) microdensitometer and band areas 
obtained using ImageQuant software. Under these conditions, closed circular form-I DNA stains with the same 
efficiency as the other two forms of DNA (Shubsda et al., unpublished). All cleavage experiments were performed 
using drug concentration ranges in which form-III DNA was not degraded into smaller fragments. In order to correct 
for errors due to loading, non-uniform illumination of the gel and vignetting due to the camera, the total amount of 
the three DNA forms in each lane were normalized to a constant. The normalization correction was always less than 
15% of the total intensity in a given lane. Four separate determinations were performed (experiments A-D) 
involving cleavage of extracellular SV40 DNA. 
Cleavage reactions for digest times of 15, 30 and 60 min were performed using the above DNA 
concentration for two different drug concentrations, 0.26 and 0.40 μM. For each concentration, the amounts of all 
three DNA forms were the same at all times, indicating that the cleavage reaction is complete within 15 min (data 
not shown). 
The stability of C-1027 in water (2.64 μM) was examined by allowing the drug to stand at 25°C for 0, 0.25, 
0.5, I, 2, 3, 6 and 12 h in the dark. The ability of the drug in each incubation solution to then cleave DNA was 
measured by adding it to SV40 DNA. The final concentrations in the reaction mixture were: SV40 DNA (25 μM), 
C-1027 (0.53 μM) in 40 mM Tris-acetate, 1 mM EDTA, pH 8.0. The cleavage reaction was allowed to proceed for 
15 min and samples were separated as previously described. [end of page 202] Analysis showed that within 
experimental error, all incubation times produced the same amount of cleavage of SV40 DNA (data not shown). 
 
2.3. Cleavage of Extracellular DNA by the C-1027 Chromophore 
The chromophore of C-1027 was isolated from the protein under subdued lighting at 4°C. Methanol saturated with 
sodium acetate (100 μl) was added to 25 μ1 of a stock solution of the antibiotic (132 μM) in water followed by the 
addition of 25 μl of water. The suspension was vortexed and allowed to stand for 30 min on ice and the precipitated 
protein was separated from the methanol-water by centrifugation. Dilutions in methanol/sodium acetate of the 
methanol-water supernatant containing the chromophore (22 μM) were prepared and added to SV40 DNA. In the 
final reaction mixture of 10 μl were: SV40 DNA (5O μM) in 40 mM Tris-acetate, pH 8.0, I mM EDTA and 20% 
methanol. Assuming a 100% recovery, the final concentrations of chromophore were (μM): 4.40, 3.61, 3.21, 2.82, 
2.42, 2.02, 1.63, 1.23. 0.84. and 0.44. After reaction for 15 min, all subsequent steps were carried out according to 
the procedure for the hoioantibiotic. 
In order to compare the kinetics of cleavage of the holoantibiotic and the chromophore, the former was 
used to cleave SV40 DNA in solutions containing methanol. The final concentrations of C-1027, in a reaction 
volume of 10 μl containing 25 μM SV40 DNA. 40 mM Tris-acetate and 20% methanol, were as earlier stated for 
studies with the holoantibiotic and extracellular DNA (25 μM). After reaction for 15 min, all subsequent steps were 
carried out according to the procedure for the holoantibiotic in buffer without methanol described above. 
 
2.4. Procedure to Reveal Abasic Sites 
Cleavage of SV40 DNA was carried out in the manner described for the reaction of intra- and extracellular DNA 
with the holoantibiotic except that the total volume was 20 μl. Sufficient putrescine to give a final concentration of 
90.5 mM was added to 10 μl of each reaction. After incubation at 37°C for 2 h, the putrescine-treated and non-
treated samples were analyzed using agarose gel electrophoresis. As a control, drug-cleaved DNA was exposed to 
 
 
90.5 mM putrescine for 0.5 to 12 h at 37°C. No change in the populations of the three DNA forms was noted, 
indicating that the amine-catalyzed decomposition of the abasic site is complete in 0.5 h (data hot shown). 
 
2.5. Cleurlage of intracellular DNA b!, the holoatrtibiotic, 
Maintenance of BSC-I (African green monkey kidney) cells was in Minimal Essential Medium, 10% calf serum 
(MEM). Infection with 5-15 plaque-forming units of SV40 virus per 6 X 105 cells was as described elsewhere [14]. 
BSC-1 cells at 6 X 105 per 35 mm plate were infected as described above with SV40 virus. Forty hours after 
infection, the plates were rinsed once and incubated for 30 min with fresh medium. Cells were treated for 2 h (37°C. 
5% CO,) with C-1027 at 5O nM and 150 nM in 1 .O ml (total volume) of medium and then rinsed twice with 
phosphate-buffered saline (PBS). Preliminary experiments found that maximal C- l027-induced damage to 
intracellular supercoiled SV40 DNA was achieved within 2 h after treatment. In addition, 1% SDS completely 
inhibited C- l027-induced SV40 DNA strand damage. Reactions were terminated by adjusting samples to a final 
concentration of 1% sodium dodecyl sulfate (SDS) and 5O μg ml-1 Proteinase K, incubating for 2 h at 37°C 
followed by the addition of 40 μg ml-1 RNAse and incubating for an additional 2 h at 37°C. The cancentrations used 
in the 5O nM experiment were (nM): 0 (control). 1, 5, 1O, 15, 20, 25, 30, 35, 40, 45, 5O. In the 150 nM experiment, 
the concentrations were (nM): 0 (control). 5, 25, 5O, 62.5, 75, 87.5, 100, 112.5, 135, 137.5, 150. 
 
2.6. Cleavage of Intracellular SV40 DNA by the C-1027 Chromophore 
The chromophore of C-1027 was isolated from the protein as described above. Dilutions of the chromophore were 
made in the water-methanol mixture, and incubation and lysis of the SV40-infected BSC-1 cells was as with the 
holoantibiotic. The concentrations used for the chromophore assay were (nM): 0 (control), 1, 5, 10, 25, 5O, 100, 
200, 250. [end of page 203] 
 
3. Results 
 
3.1. Kinetic theory 
We fitted the fractional populations of forms I, II and III of SV40 DNA to the kinetic model described below by 
minimizing D, the sum of the squares of the differences between measured fractional populations and fractional 
populations calculated from the model. The Simplex or other search method was used to find the values of 
parameters (initial populations of the three species and rate constants) which minimize D. 
The chromophore portion of C- 1027 is capable of causing both single (ss) and double (ds) strand cleavage 
of DNA [15- 17]. The rate processes considered are: form I → form II (ss), form II → form III (ss and ds) and form 
I → form III (ds). All rate expressions are assumed to be second order. In fact, the ss cleavage of form II to produce 
form III is not a single second-order reaction, but is instead many second-order reactions with different rate 
constants, corresponding to cleavage of form II with an assortment of nicks in it. It is apparently sufficient, for the 
experiments analyzed here, to represent all of them by using a single reaction with a single effective rate constant 
which is an average of the true rate constants. The rate expressions can then be solved as long as [C-1027] = [C-
1027]o f(t) with f(t) independent of the initial drug concentration [C-1027]o. The expressions for the amounts of the 
three forms of DNA after digest are similar to those from the pseudo-first-order equations, except that where the 
 
latter contain ki , the former contain kiG( ), where ki is a second-order rate constant and G is a function of , the 
digest time. The pseudo first order equations correspond to f(t) = 1. 
 
 
Let k1 and k4 be the rate constants for ss and ds cutting of form I, producing forms II and III respectively, 
and let k2 and  be the rate constants for ss and ds cutting of form II, producing form III. Then the solutions to the 
kinetic equations are as follows 
 
In Eqs. (l)-(3), we denote [C- 1027]o, the initial drug concentration, by [D]o. The drug concentration at time 
t is [D]of(t). Since G( ) is not known, one cannot get actual values of rate constants. However, by varying drug 
concentration at constant time, one can obtain quantities proportional to the rate constants and ratios of rate 
constants. The parameters determined are intensities for zero drug concentration (initial intensities) and rate 
constants multiplied by G( ). 
 
3.2. Cleavage of Extracellular SV40 DNA with the Holoantibiotic 
Four experiments, A-D, involving cleavage of extracellular SV40 DNA by C-1027, were analyzed. A photograph of 
an agarose gel for one of the experiments is shown in Fig. 1, while fits to observed intensities for a second 
experiment, using the theoretical expressions, are shown in Fig. 2. The [end of page 204] 
 
populations of the three forms of DNA as a function of concentration of C-1027 are fit to populations calculated 
from the theoretical model, which includes ss and ds cutting. There are six parameters: [I]o, the initial population of 
form I; [II],, the initial population of form II; [III]o, the initial population of form III; k1G( ), where k1 is the rate 
constant for the I-II conversion; (k2, + )G( ), where (k, + ) is the effective rate constant for the II-III 
conversion; and k4G( ), where k4 is the rate constant for the I-III conversion. Table 1 shows the values of 
parameters determined for experiments A-D. The errors are standard errors from the fitting procedure. Averaging 
the four sets of results, we find k1G = 1.85±t 0.65, k2G = 0.20 ± 0.09, and k4G = 1.05 ± 0.31 (μM)-1, where the stated 
errors are now standard deviations. 
 
 
The ratio of rate constants, ki/kj, is obtained by dividing kiG( ) by kjG( ). The ratio k1/k2 was 10, 12, 9 and 
7 for experiments A-D respectively, with very large errors because of the small value of k2. Assuming that, for 
conversion of II to III, cuts on opposing strands must be within approximately five nucleotides of each other and that 
forms I and II bind drug equally well, this ratio should be about 500 for a genome the size of SV40 DNA (5.2 kbl). 
The fact that the ratio is much less indicates that C-1027 exhibits base or sequence specificity. It has recently been 
shown that the drug most often cleaves at adenine and thymine residues of DNA [16,17]. 
For the ratio of ss to ds cutting, k1/k4, we obtain, by averaging experiments A-D. 1.72 ± 0.24. Weighting 
each value by the reciprocal of the uncertainty, the average of the four values is 1.78. Thus, outside the cell, ss 
cutting is almost twice as likely to occur as ds cutting. 
 
3.3. Cleavage of intracellular SV40 DNA wjith the holoantihiotic 
As described in Section 2, BSC-1 cells infected with the SV40 virus were treated with various amounts of C- 1027. 
and after two hours the DNA was recovered and analyzed using agarase gel techniques. One of these experiments 
had a maximum drug concentration of 50 nM which reduced the population of form-1 DNA by only half of its initial 
value. The resulting plots of populations versus [C-1027] were essentially linear. making it impossible to determine 
three independent rate parameters. A second experiment, using 150 nM as a maximum drug concentration, resulted 
in loss of approximately 90% of the initial concentration of form-l DNA. 
 
[end of page 205] 
For the 50-nM experiment, experimental and calculated populations are given in Fig. 3. The values of the 
correlation coefficient, initial population of DNA (arbitrary units) and slope (μM)-1 were respectively: form I, 0.99, 
0.82, -8.44; form II, 0.22, 0.20, 0.28; form III, 0.99, - 0.02, 8.16. Theoretically, the slopes for the linear plots for 
forms I, II and III should be equal, respectively, to -(k1 + k4)[I]oG, (k1[I]o – k2[II]o)G and (k2[11]o + k4[I]o)G, where G 
= G(∞). The value of (k1 + k4)G(∞) was 10.3 ± 0.4 (μM)-1. If we assume that k2[II]o is much less than k4[I]o, k4G is 
equal to 8.16/0.82 = 9.3 ± 0.5 (μM)-1. Alternatively, the slope of form II gives k1G = 0.34 + 0.24k2G (μM)-1, and, 
since k4 cannot be greater than k1, k1G < 0.45. Thus, k4 is much larger than k1. 
The 150-nM experiment (results plotted in Fig. 4) was analyzed according to the kinetic model used for the 
experiments involving purified DNA. The results of the calculations are given in Table 1. The value of (k1G+ k4G), 
12.9 ± 1.5 (μM)-1, agrees with the corresponding value found from the 50-nM experiment. We note that k4 is four 
times as large as k1. There is much more ds cleavage inside than outside the cell, Table 1. It also appears that the 
overall rate of cleavage, k1 + k4, is higher inside than outside the cell. 
We have assumed that during the two hour incubation in the cell studies, cutting is completed be- 
 
 
 
 
cause drug has been exhausted. If this were not the case, the reported parameters represent kiG( ), where G( ) < 
G(∞), so that the actual values of ki are higher relative to the extracellular values than appears from the model. 
Furthermore, G( ) may be a different function of time inside the cell than outside. If more or faster processes which 
degrade the drug are available inside the cell, the effective drug concentration at time  is lower than outside. Then 
the ratio of values of ki inside the cell to ki outside is actually higher than what we measure. On the other hand, if the 
drug is protected from degradation inside the cell, its effective concentration at time  is larger than outside, and the 
ratio is actually smaller. 
 
3.4. Cleallage of extra- and intracellular DNA with the C- IO2 7 chromophore 
Cleavage experiments were performed on purified extracellular SV40 DNA using the chromophore of C-l 027 
instead of the holoantibiotic. There was no evidence of cleavage of form-III DNA to produce smaller fragments, so 
the data were normalized to constant total DNA. Then, assuming k3 (rate constant for cleavage of form-III DNA) to 
be 0, we fitted amounts of forms I, II and III as functions of chromophore concentration to the model specified by 
Eqs. (1)-(3). [end of page 206] 
The resulting values of k1G, k2G, and k4G for the extracellular SV40/ C-1027 free chromophore experiment 
are given in Table 2. As can be seen, the ratio of ss/ds cleavage is nearly identical to that obtained using the 
holoantibiotic. The ratio k1/k4 may actually be larger than that for the holoantibiotic, approaching the value reported 
by Xu et al. [16] of ≈ 4 for cleavage of pBR 322 DNA with the chromophore. However, the errors are large because 
quantitative studies with the isolated chromophore were difficult to carry out. First, the chromophore is unstable 
when not bound to the apoprotein [18]. Also, since the free chromophore was obtained using a methanol 
precipitation procedure, its concentration was not accurately known in the cleavage reactions (a 100% recovery was 
 
 
assumed). The values of kiG for the chromophore are much smaller than those in Table 1 for the holoantiobotic, 
perhaps because the actual concentration of chromophore is lower than that stated in Section 2. 
We also performed extracellular experiments using the holoantibiotic in the presence of methanol, which 
was used in the precipitation procedure for the chromophore, and so was present in these cleavage experiments for 
comparison. Analysis of these data using the kinetic model led to the following values of rate constants: k1G = 1.01 
± 0.18, k2G = -0.17 ± 11. k4G = 0.56 ± 0.30 (μM)-1. Rate constants are indeed lower in the presence of methanol. but 
k1/k4 is I .80 ┴ 1 .0l . the same as in the absence of methanol. The alcohol probably exerts its effect by slowing the 
processes leading to the activated chromophore and/or quenching the drug-diradical after it is formed. As is evident 
from Tables 1 and 2, the kinetic parameters for the chromophore and the holoantibiotic cleaving intracellular DNA 
are comparable. 
 
3.5. C-1027 Cleavage of DNA Following Post-Treatment with Putrescine 
In order to check for the presence of abasic sites created by C-1027. DNA cleaved by the drug was exposed to 
excess putrescine. Neocarzinostatin (NCS) and bleomycin (BLM) are known to produce abasic DNA sites which 
can be converted into a strand break using putrescine [19]. Previous studies with C- 1027 indicated that the drug can 
abstract a hydrogen from the 4’ position of the sugar producing a 4’ hydroxylated abasic site [16,17]. For SV40 
DNA which has been treated with C-1027. there are a number of possibilities. If the drug attacks form-l DNA by 
eliminating a base without producing a strand break. form I would not be converted into form-II DNA. However, 
subsequent treatment with putrescine would break the strand at the abasic site causing conversion of form I to form 
II. If the drug produced two abasic sites sufficiently close to one another but on opposing strands, exposure to amine 
would cause form 1 to be directly converted into form-III DNA. 
Quantitative analysis of agarose gel data with and without post-treatment with putrescine was carried out. 
The results of linear regression analysis on the fractional populations of forms I, II and III for the extracellular 
studies are shown in Fig. 5. Analysis of the data gave the following values for rate constants: k1G = 1.07 ┴ 0.61. k2G 
= 0.92 ± 0.26. k4G = 5.35 ± 0.61. The k1/k4, ratio (0.2) differs drastically from the ratio for extracellular cleavage 
without putrescine (Table 1). The ratio is similar to that obtained from the intracellular data, 0.25 ± 0.11. This may 
be a result of the ability of putrescine to mimic the chemistry occurring inside the cell, wherein lysine groups on 
histones or polyamines like 
 
[end of page 207] 
 
spermidine can cause abasic sites proximal to ss DNA breaks to become strand breaks through β elimination. 
Comparison of the curves in Fig. 2 and Fig. 5 demonstrates that putrescine has practically no effect on the form I 
 
 
population, while converting form II with abasic sites into form III. In the case of putrescine post-treatment of the 
intracellular samples, changes in the relative populations of SV40 DNA were not observed (data not shown). 
 
4. Discussion 
By fitting the measured intensity data to a kinetic model, quantities proportional to rate constants for cleavage of 
SV40 DNA by C- 1027 were determined. The fits can be seen in Figs. 2-5, and the measured rate parameters and 
their errors are given in Tables 1 and 2. The striking result is that the apparent rate constant for ds cleavage in the 
cell is 5-10 times higher as compared to extracellular experiments. As stated in the results section, G( ) may be a 
different function of time inside the cell than outside due to various processes inside the cell which may degrade the 
drug. If this is the case, it would be reflected in the k values inside versus outside the cell. However, the ratio of 
single- to double-strand cleavage inside the cell is much lower than outside, and this is unaffected by different G( ) 
values. Furthermore, putrescine treatment of extracellular samples cleaved by C-1027 yielded a ratio of k1/k4 similar 
to that obtained in the intracellular assay. The most likely reason for the high number of ds breaks in the cell is 
caused by the ability of proximal amine functions on histones or polybasic amines like spermidine to induce a break 
at an abasic site. This argument has been used to explain the increased amount of ds breaks observed for 
neocarzinostatin in intracellular studies [19] and it may apply to C-1027 as well. 
The reason for the higher rate of cleavage of intracellular versus extracellular SV40 DNA by C-1027 is 
unclear. However, both the free chromophore and the holoantibiotic exhibit enhanced cleavage inside the cell, as 
measured by the disappearance of form-1 DNA (k1 + k4). It may be that in order for the drug to cleave extracellular 
DNA, the chromophore must first be released from the protein part of the antibiotic. It is apparent from the studies 
on the stability of the holoantibiotic in water that the “activator” for C-1027 is DNA itself. Outside the cell, the free 
chromophore could be partially deactivated by components in the medium before it reaches its DNA target, thus 
producing lower rates. For intracellular DNA, the holoantibiotic must first bind to the cell membrane at which point 
it could release the chromophore. Once inside, it may be protected from damage and/or more efficiently delivered to 
SV40 chromatin. 
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